| 20.92 Delayed Data As of 4:00pm ET |  +0.94 / +4.70%Today’s Change | 19.41 Today|||52-Week Range 120.40 | -70.34% Year-to-Date |
| 3 Glaring Problems in Tilray's Q3 Results Nov 13 / MotleyFool.com - Paid Partner Content | Despite Poor Financial Results, This Pot Stock May Be Worth a Second Look Nov 12 / MotleyFool.com - Paid Partner Content |
| Tilray Inc (TLRY) Q3 2019 Earnings Call Transcript Nov 13 / MotleyFool.com - Paid Partner Content | 5 Marijuana Stocks to Watch This Week Nov 11 / MotleyFool.com - Paid Partner Content |
| Tilray Sales Blast Higher in Mixed Q3 Nov 12 / MotleyFool.com - Paid Partner Content | 3 Things to Watch in the Stock Market This Week Nov 10 / MotleyFool.com - Paid Partner Content |
| 3 Huge Questions Tilray Will Have to Answer With Its Third-Quarter Report Nov 12 / MotleyFool.com - Paid Partner Content | It's Time to Buy Cannabis Stocks, Says 1 Wall Street Firm Nov 08 / MotleyFool.com - Paid Partner Content |
| Previous close | 19.98 |
| Today’s open | 20.35 |
| Day’s range | 20.23 - 21.26 |
| Volume | 2,268,081 |
| Average volume (3 months) | 1,668,048 |
| Market cap | $2.0B |
| Earnings growth (last year) | -873.51% |
| Earnings growth (this year) | -64.92% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +110.00% |
| P/E ratio | NM |
| Price/Sales | 135.76 |
| Price/Book | 9.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| HRTXHeron Therapeutics I... | +0.18 | +0.80% |
| XNCRXencor Inc | +0.76 | +2.01% |
| EIDXEidos Therapeutics I... | -1.95 | -3.39% |
| XLRNAcceleron Pharma Inc | +0.19 | +0.44% |
| Next reporting date | March 23, 2020 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $43.1M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -157.02% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Nanaimo, British Columbia |
